Cross-talk between β
2-adrenergic receptor (β
2AR) and Toll-like receptor (TLR) signalling pathways. (a) β
2AR agonists suppress nuclear factor-κB (NF-κB) activation by increasing cytoplasmic β-arrestin 2, which stabilizes the NF-κB/inhibitor of NF-κB (IκBα) complexes in cytoplasm (i) or by activating cAMP response element binding protein (CREB), which then produces competition between CREB-binding protein (CBP) and NF-κB in the nucleus (ii). (b) TLR4-dependent signals lead to the following steps both in the presence or absence of β
2AR agonists:

TLR4-dependent down-regulation of β
2AR expression,

down-regulation of β-arrestin 2,

release of NF-κB/IκBα complexes in the cytoplasm,

degradation of IκBα, and

translocation of NF-κB to the nucleus and transcription of its target genes.